Preserving Mfn2 activity together with appropriate MAPK regulation is therefore essential for maintaining mitochondrial quality control, promoting neuronal survival, and may offer a promising therapeutic avenue for mitigating stroke-related brain damage [15,20,64]. This evidence concerns the gene MFN2 and stroke disorder.